|
Journal of Lipid Research, Vol. 42, 1474-1482, September 2001
Copyright © 2001 by Lipid Research, Inc.
Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein
Kristin Gillotte-Taylora,
Agnès Boulliera,
Joseph L. Witztuma,
Daniel Steinberga, and
Oswald Quehenbergera
a Department of Medicine, University of California, San Diego, La Jolla, CA 92093
Correspondence to:
Oswald Quehenberger, at the University of California, San Diego, Department of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0682., oquehenberger{at}ucsd.edu (E-mail)
Scavenger receptor class B type I (SR-BI) has been established as the primary mediator of the selective transfer of lipids from HDL to mammalian cells. In addition to its role in cholesterol metabolism, SR-BI has been shown to bind apoptotic cells and thus could in theory also function as a scavenger receptor. We now show that SR-BI binds oxidized LDL (OxLDL) with high affinity (Kd of 4.0 ± 0.5 µg/ml) and mediates internalization and degradation to an extent comparable to that of other scavenger receptors, when normalized to binding activity. The best competitors for OxLDL binding to SR-BI were oxidized lipoproteins, whereas native or acetylated lipoproteins only competed for a small fraction of OxLDL binding. Both the isolated lipids and the isolated protein from OxLDL bound with high affinity to SR-BI and showed partial reciprocal competition. Monoclonal antibody EO6, an antibody against oxidized phospholipids, and 1-palmitoyl-2-(5-oxovaleroyl) phosphatidylcholine (POVPC) both competed effectively with intact OxLDL and with isolated lipids from OxLDL for SR-BI binding.
Together, these results demonstrate a potential function of SR-BI, in addition to its role in selective uptake of lipids, to mediate internalization of OxLDL by macrophages and suggest a central role for oxidized phospholipids in this process. Gillotte-Taylor, K., A. Boullier, J. L. Witztum, D. Steinberg, and O. Quehenberger. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 2001. 42: 1474;1482.
Supplementary key words:
oxidized LDL, SR-BI, oxidized phospholipid, scavenger receptor

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Hartvigsen, M.-Y. Chou, L. F. Hansen, P. X. Shaw, S. Tsimikas, C. J. Binder, and J. L. Witztum
The role of innate immunity in atherogenesis
J. Lipid Res.,
April 1, 2009;
50(Supplement):
S388 - S393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E. R. Miller, M.-J. Shin, C. J. Binder, S. Horkko, R. M. Krauss, M. J. Chapman, et al.
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
J. Lipid Res.,
October 1, 2008;
49(10):
2230 - 2239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Luangrath, M. R. Brodeur, D. Rhainds, and L. Brissette
Mouse CD36 Has Opposite Effects on LDL and Oxidized LDL Metabolism In Vivo
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2008;
28(7):
1290 - 1295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Ashraf, N. S. Kar, X. Chen, J. Choi, R. G. Salomon, M. Febbraio, and E. A. Podrez
Specific Oxidized Phospholipids Inhibit Scavenger Receptor BI-mediated Selective Uptake of Cholesteryl Esters
J. Biol. Chem.,
April 18, 2008;
283(16):
10408 - 10414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawai, T. Nishikawa, Y. Shiba, S. Saito, K. Murota, N. Shibata, M. Kobayashi, M. Kanayama, K. Uchida, and J. Terao
Macrophage as a Target of Quercetin Glucuronides in Human Atherosclerotic Arteries: IMPLICATION IN THE ANTI-ATHEROSCLEROTIC MECHANISM OF DIETARY FLAVONOIDS
J. Biol. Chem.,
April 4, 2008;
283(14):
9424 - 9434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sun, B. B. Boyanovsky, M. A. Connelly, P. Shridas, D. R. van der Westhuyzen, and N. R. Webb
Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI
J. Lipid Res.,
December 1, 2007;
48(12):
2560 - 2570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Binder, K. Hartvigsen, and J. L. Witztum
Promise of Immune Modulation to Inhibit Atherogenesis
J. Am. Coll. Cardiol.,
August 7, 2007;
50(6):
547 - 550.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsimikas, S. Kiechl, J. Willeit, M. Mayr, E. R. Miller, F. Kronenberg, Q. Xu, C. Bergmark, S. Weger, F. Oberhollenzer, et al.
Oxidized Phospholipids Predict the Presence and Progression of Carotid and Femoral Atherosclerosis and Symptomatic Cardiovascular Disease: Five-Year Prospective Results From the Bruneck Study
J. Am. Coll. Cardiol.,
June 6, 2006;
47(11):
2219 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Quehenberger
Thematic Review Series: The Immune System and Atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis
J. Lipid Res.,
August 1, 2005;
46(8):
1582 - 1590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Binder, P. X. Shaw, M.-K. Chang, A. Boullier, K. Hartvigsen, S. Horkko, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum
Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis
J. Lipid Res.,
July 1, 2005;
46(7):
1353 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Boullier, P. Friedman, R. Harkewicz, K. Hartvigsen, S. R. Green, F. Almazan, E. A. Dennis, D. Steinberg, J. L. Witztum, and O. Quehenberger
Phosphocholine as a pattern recognition ligand for CD36,
J. Lipid Res.,
May 1, 2005;
46(5):
969 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cai, M. C. de Beer, F. C. de Beer, and D. R. van der Westhuyzen
Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake
J. Biol. Chem.,
January 28, 2005;
280(4):
2954 - 2961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rhainds, P. Bourgeois, G. Bourret, K. Huard, L. Falstrault, and L. Brissette
Localization and regulation of SR-BI in membrane rafts of HepG2 cells
J. Cell Sci.,
July 1, 2004;
117(15):
3095 - 3105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Marsche, R. Zimmermann, S. Horiuchi, N. N. Tandon, W. Sattler, and E. Malle
Class B Scavenger Receptors CD36 and SR-BI Are Receptors for Hypochlorite-modified Low Density Lipoprotein
J. Biol. Chem.,
November 28, 2003;
278(48):
47562 - 47570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. I. Miller, D. S. Worrall, C. D. Funk, J. R. Feramisco, and J. L. Witztum
Actin Polymerization in Macrophages in Response to Oxidized LDL and Apoptotic Cells: Role of 12/15-Lipoxygenase and Phosphoinositide 3-Kinase
Mol. Biol. Cell,
October 1, 2003;
14(10):
4196 - 4206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bruneau, S. Richard, F. Silvy, A. Verine, and D. Lombardo
Lectin-like Ox-LDL Receptor Is Expressed in Human INT-407 Intestinal Cells: Involvement in the Transcytosis of Pancreatic Bile Salt-dependent Lipase
Mol. Biol. Cell,
July 1, 2003;
14(7):
2861 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rigotti, H. E. Miettinen, and M. Krieger
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
Endocr. Rev.,
June 1, 2003;
24(3):
357 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Osgood, D. Corella, S. Demissie, L. A. Cupples, P. W. F. Wilson, J. B. Meigs, E. J. Schaefer, O. Coltell, and J. M. Ordovas
Genetic Variation at the Scavenger Receptor Class B Type I Gene Locus Determines Plasma Lipoprotein Concentrations and Particle Size and Interacts with Type 2 Diabetes: The Framingham Study
J. Clin. Endocrinol. Metab.,
June 1, 2003;
88(6):
2869 - 2879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ahmed, A. Ravandi, G. F Maguire, A. Kuksis, and P. W Connelly
Formation of apolipoprotein AI-phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophages
Cardiovasc Res,
June 1, 2003;
58(3):
712 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. de Beer, Z. Zhao, N. R. Webb, D. R. van der Westhuyzen, and W. J. S. de Villiers
Lack of a direct role for macrosialin in oxidized LDL metabolism
J. Lipid Res.,
April 1, 2003;
44(4):
674 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Hazen and G. M. Chisolm
Oxidized phosphatidylcholines: Pattern recognition ligands for multiple pathways of the innate immune response
PNAS,
October 1, 2002;
99(20):
12515 - 12517.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-K. Chang, C. J. Binder, M. Torzewski, and J. L. Witztum
From the Cover: C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids
PNAS,
October 1, 2002;
99(20):
13043 - 13048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bultel-Brienne, S. Lestavel, A. Pilon, I. Laffont, A. Tailleux, J.-C. Fruchart, G. Siest, and V. Clavey
Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins
J. Biol. Chem.,
September 20, 2002;
277(39):
36092 - 36099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Friedman, S. Horkko, D. Steinberg, J. L. Witztum, and E. A. Dennis
Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids. IMPORTANCE OF SCHIFF BASE FORMATION AND ALDOL CONDENSATION
J. Biol. Chem.,
February 22, 2002;
277(9):
7010 - 7020.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|